Research Topic · Peer-Reviewed

Malignant Diseases Screening and Detection

Malignant diseases screening and detection refers to the methods and strategies used to identify cancers and related malignant conditions, ideally at an early and more treatable stage. Screening involves testing individuals who may not yet have symptoms in order to detect disease or precursors early, while detection…

Curated from this journal's research 📚 8 peer-reviewed articles cited Cited 19× across the literature 🔖 ISSN 2372-6601 🗓 Reviewed July 2026

Overview

Malignant diseases screening and detection refers to the methods and strategies used to identify cancers and related malignant conditions, ideally at an early and more treatable stage. Screening involves testing individuals who may not yet have symptoms in order to detect disease or precursors early, while detection more broadly encompasses the diagnostic processes that confirm and characterize a malignancy once it is suspected. These approaches draw on clinical evaluation, imaging, laboratory tests, biomarkers, and tissue examination, and their effectiveness depends on the accuracy of the tests and the biology of the disease being sought. In hematology and oncology, screening and detection are central to improving outcomes, since early identification of malignancy and the use of reliable biomarkers can guide timely treatment. Research in this journal addresses these themes, including non-invasive screening for prostate cancer using prostatic fluid biomarkers, the early detection of post-transplant lymphoproliferative disorder through head and neck manifestations, and the characterization of acquired abnormalities in coagulation parameters in aggressive hematological malignancies. Diagnostic studies of cytology and the histopathological evaluation of lymphoid lesions further reflect the role of laboratory and tissue-based detection. This page gathers peer-reviewed, open-access research relevant to the screening, detection, and diagnosis of malignant diseases.

Research published in this journal

8 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 8 articles above have been cited 19 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Malignant Diseases Screening and Detection, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Hematology and Oncology Research (ISSN 2372-6601).

Journal editorial board
Jayadev Manikkam Umakanthan · United States Shuaiying Cui · United States Benedetto Sacchetti · Italy

This page summarises published research for orientation; it is not medical or professional advice.